Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment

NCT01580306 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: BI 201335
DRUG: BI 201335

Sponsor

Boehringer Ingelheim